Literature DB >> 8527832

Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid.

J L Wallace1, T Le, L Carter, C B Appleyard, P L Beck.   

Abstract

Hapten-induced colitis is a widely used model for the study of the intestinal inflammation and for the testing of novel therapies. However, the hapten utilized in this model, trinitrobenzene sulfonic acid, is difficult to obtain in some countries. We therefore compared this hapten to two structurally related haptens to determine if they could be substituted for trinitrobenzene sulfonic acid in terms of inducing chronic colitis in the rat. Rats received one of the three haptens intracolonically, and the severity of colonic inflammation was assessed 3 and 14 days later. Dinitrobenzene sulfonic acid produced colonic inflammation and ulceration that was indistinguishable from that induced by trinitrobenzene sulfonic acid at both time points. On the other hand, dinitrochlorobenzene produced acute colitis (3 days postadministration), but by Day 14 this inflammation had subsided. Dinitrobenzene sulfonic acid and trinitrobenzene sulfonic acid produced comparable levels of granulocyte infiltration into the colon (as measured by tissue myeloperoxidase activity and histology) at both time points. These studies suggest that for studies of up to at least 2 weeks in duration, dinitrobenzene sulfonic acid and trinitrobenzene sulfonic acid produce comparable levels of colonic inflammation. Dinitrobenzene sulfonic acid therefore offers a useful and less expensive alternative to trinitrobenzene sulfonic acid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527832     DOI: 10.1016/1056-8719(95)00001-x

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  30 in total

1.  Damage to the enteric nervous system in experimental colitis.

Authors:  S Sanovic; D P Lamb; M G Blennerhassett
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis.

Authors:  C B Appleyard; J L Williams; C A Hathaway; W H Percy
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

3.  Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis.

Authors:  S Blau; R Kohen; P Bass; A Rubinstein
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

4.  Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.

Authors:  S Sturiale; G Barbara; B Qiu; M Figini; P Geppetti; N Gerard; C Gerard; E F Grady; N W Bunnett; S M Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.

Authors:  C P Tran; G A Cook; N D Yeomans; L Thim; A S Giraud
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis.

Authors:  Kyle L Flannigan; Terence A Agbor; Rory W Blackler; Janice J Kim; Waliul I Khan; Elena F Verdu; Jose G P Ferraz; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-03       Impact factor: 11.205

Review 7.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

8.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes.

Authors:  Tareq Taha Jubeh; Yechezkel Barenholz; Abraham Rubinstein
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 10.  Visceral pain: the neurophysiological mechanism.

Authors:  Jyoti N Sengupta
Journal:  Handb Exp Pharmacol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.